期刊文献+

HLA-E在肝癌细胞系中的表达 被引量:2

Expression of human leukocyte antigen E in hepatocellular carcinoma cell lines
暂未订购
导出
摘要 目的:研究人类白细胞抗原E(HLA-E)在肝癌细胞系中的表达情况。方法:通过real-time PCR和Western blotting技术研究5种肝癌细胞系和胎肝细胞系中HLA-E mRNA和蛋白的表达情况,进行相对定量分析。结果:Real-time PCR检测显示,HepG2细胞、Bel7402细胞、PLC细胞、MHCC97细胞和Hep3B2.1-7细胞这5种肝癌细胞系与L02胎肝细胞系的HLA-E mRNA水平比较,除Hep3B2.1-7细胞表达几乎接近缺失(P<0.01)外,其余无显著差异(P>0.05)。HepG2细胞、Bel7402细胞、PLC细胞、MHCC97细胞和Hep3B2.1-7细胞与L02细胞的HLA-E蛋白水平比较,差异显著(P<0.01),其中Hep3B2.1-7细胞表达缺失。结论:肝癌细胞系的HLA-E mRNA和蛋白表达不同步,可能存在转录后调控。 AIM: To investigate the human leukcyte antigen E (HLA- E) expression in hepatocellular carci- noma cell lines. METHODS: The techniques of real - time PCR and Western blotting were used to study the HLA - E ex- pression in the 5 cell lines of hepatocellular carcinoma and a fetal liver cell line at mRNA and protein levels. RESULTS : The results of real - time PCR showed that no statistical difference of HLA - E mRNA level between fetal liver cell L02 and other 4 cell lines of hepatocellular carcinoma ( HepG2, Be17402, PLC and MHCC97 ) was observed, and almost absence of HLA- E mRNA expression in Hep3B2.1 -7 cells was detected. However, the results of Western blotting showed that there was a significant statistical difference of HLA - E protein levels between L02 cells and the 5 cell lines of hepatocellular carcinoma (HepG2, Be17402, PLC, MHCC97 and Hep3B2.1 -7), and no HLA - E protein in Hep3B2.1 -7 cells was detectable. CONCLUSION: Asynchronization of HLA - E expression between mRNA and protein levels was found in hepatocellular carcinoma cell lines.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第10期1884-1886,共3页 Chinese Journal of Pathophysiology
基金 国家重点基础研究发展计划(973分课题)(No.2009CB522404) 国家自然科学基金面上项目(No.30571769 No.30972914) 十一五科技攻关(No.2008ZX10002-025) 广东省科技计划(No.2009A030200006) 教育部新教师基金资助项目(No.20100171120087 No.20100171120084) 广东省自然科学基金博士启动项目(No.10451130001004472)
关键词 人类白细胞抗原E 肝细胞癌 胎肝细胞 基因表达 Human leukocyte antigen E Hepatocellular carcinoma Fetal liver cells Gene expression
  • 相关文献

参考文献11

  • 1Malmberg K J, Levitsky V, Norell H, et al. IFNγ protects short - term ovarian carcinoma cell lines from CTL lysis via CD94/NKG2A dependent mechanism [ J ]. J Clin Invest, 2002,110 (10) : 1515 - 1523.
  • 2Moretta A, Bottino C, Vitale M, et al. Receptors for HLA class -I molecules in human natural killer cells [ J ]. Annu Rev Immunol, 1996, 14(4) : 619 -648.
  • 3Lee N, Llano M, Carretero M, et al. HLA -E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A[J]. Proc Natl Acad Sci U S A, 1998, 95(9): 5199 - 5204.
  • 4Pyo CW, Williams LM, Moore Y, et al. HLA - E, HLA - F and HLA - G polymorphism: genornic sequence defines haplotype structure and variation spanning the nonclassical class igenes[J]. Immunogenetics, 2006, 58(4): 241 - 251.
  • 5Algarra I, Garcia - Lora A, Cabrera T, et al. The selection of tumor vailants with altered expression of classical and nonclassical MHC class I molecules:implications for tumor immune escape [ J ]. Cancer lmmunol Immunother,2004,53 (10) :904 -910.
  • 6Marin R, Ruiz - Cabello F, Pedrinaci S, et al. Analysis of HLA- E expression in human tumors [ J ]. Immunogene- tics,2003,54( 11 ) :767 -775.
  • 7张彤,曾宪成,方天翎,陈文捷,聂常富,李华,陈规划.肝癌Bel7402细胞HLA-E基因上调对NK细胞体外杀伤作用的影响[J].中国病理生理杂志,2010,26(11):2081-2085. 被引量:3
  • 8方天翎,李华,张彤,曾宪成,陈规划.HLA-E siRNA沉默肝癌细胞HLA-E基因的表达[J].中国药理学通报,2010,26(1):29-32. 被引量:3
  • 9方天翎,李华,张彤,曾宪成,陈规划.肝癌HLA-E基因的表达及对判断肝癌肝移植疗效的意义[J].临床外科杂志,2009,17(9):595-597. 被引量:3
  • 10Majumder D,Bandyopadhyay D,Chandra S, et al. Lack of HLA - E surface expression is due to deficiency of HLA - E transcripts in the malignan the matopoietic cells of leu- kemic patients[J]. Leuk Res,2006,30(2) :242 -245.

二级参考文献22

  • 1Xiao-Yong LEI Miao ZHONG Lan-Fang FENG Bing-Yang ZHU Sheng-Song TANG Duan-Fang LIAO.BcI-XL Small Interfering RNA Enhances Sensitivity of Hepg2 Hepatocellular Carcinoma Cells to 5-Fluorouracil and Hydroxycamptothecin[J].Acta Biochimica et Biophysica Sinica,2006,38(10):704-710. 被引量:5
  • 2Algarra I,Garcia-Lora A,Cabrera T,et al.The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules:implications for tumor immune escape[J].Cancer Immunol Immunother,2004,53(10):904-910.
  • 3Marin R,Ruiz-Cabello F,Pedrinaci S,et al.Analysis of HLA-E expression in human tumors[J].Immunogenetics,2003,54(11):767-775.
  • 4Kaiser BK,Pizarro JC,Kerns J,et al.Structural basis for NKG2A/CD94 recognition of HLA-E[J].PNAS,2008,105(18):6696-6701.
  • 5Kanto T.Virus associated innate immunity in liver[J].Front Biosci,2008,13:6183-6192.
  • 6Majumder D,Banerijee S,Bandyopadhyay D,et al.Lack of HLA-E surface expression is due to deficiency of HLA-E transcripts in the malignan the matopoietic cells of leukemic patients[J].Leuk Res,2006,30(2):243-245.
  • 7Moretta A,Bottino C,Vitale M,et al.Receptors for HLA class-I molecules in human natural killer cells[J].Annu Rev Immunol,1996,14(4):619-648.
  • 8Lee N,Liano M,Carretero M,et al.HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A[J].Proc Natl Acad Sci USA,1998,95(4pp):5199-5204.
  • 9Kaiser BK,Pizarro JC,Kems J,et al.Structural basis for NKG2A/CD94 recognition of HLA-E[J].PNAS,2008,105(18):6696-6701.
  • 10Wooden SL,Kalb SR,Cotter RJ,et al.Cutting edge:HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis[J].J Immunol,2005,175(3):1383-1387.

共引文献6

同被引文献24

  • 1刘俊,蒋业贵,王宇明.HLA-DR、-DQ在慢性乙型肝炎肝组织中的表达及其意义[J].第三军医大学学报,2004,26(7):572-572. 被引量:3
  • 2任晖,欧建锋.HLA-G在胃癌组织中表达的研究分析[J].中国现代医学杂志,2005,15(17):2602-2603. 被引量:1
  • 3张义,邹雄,杨晓静,李晓丽,赵胜梅,高艳景.淋巴细胞HLA—B表达与胃癌分化转移的关系[J].中华肿瘤杂志,2007,29(1):49-52. 被引量:8
  • 4Lankat-Buttgereit B, Tampe R. The transporter associated with antigen processing: function and implications in hu- man diseases [ J ]. Physiol Rev,2002,82 ( 1 ) : 187-204.
  • 5Charron D. Immunogenetics today: HLA, MHC and much more [ J ]. Curr Opin Immunol, 2005,17 (5) : 493-497.
  • 6Satoh E, Mabuchi T, Satoh H, et al. Reduced expression of the transporter associated with antigen processing 1 mol- ecule in malignant glioma cells, and its restoration by in- terferon-γ and-β [ J ]. J Neurosurg, 2006, 104 ( 2 ) : 264- 271.
  • 7Kaczmarek M, Frydrychowicz M, Rubis B, et al. Analysis of expression of MHC class Ⅰ molecules and TAP genes in malignant human cell lines [ J ]. Folia Histochem Cytobiol, 2007,45(3) :205-214.
  • 8Alimonti J, Zhang Q J, Gabathuler R, et al. TAP expres- sion provides a general method for improving the recogni- tion of malignant cells in vivo [ J ]. Nat Biotechnol, 2000, 18(5) :515-520.
  • 9Ma W, Lehner PJ, Cresswell P, et al. Interferon-γ rapid- ly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells [ J ]. J Biol Chem, 1997,272 ( 26 ) : 16585-16590.
  • 10Tao J, Li Y, Liu YQ, et al. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity [ J]. J Invest Dermatol,2008,128 (8) : 1991-1996.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部